ANDE

Waltham, United States Founded: 2000 • Age: 26 yrs
Rapid DNA systems are provided for forensic identification and diagnostics.

About ANDE

ANDE is a Healthcare company based in Waltham (United States) founded in 2000 by Richard Selden. Rapid DNA systems are provided for forensic identification and diagnostics. It operates on a Professional Services model. ANDE has raised $131.3 million across 11 funding rounds from investors including HHS and Ojp. The company has 49 employees. ANDE offers products and services including Rapid DNA for Human Identification, Rapid DNA for Energy, and Rapid DNA for Biosurveillance. Its focus areas include Technology, Biotechnology and DNA Analysis. Its legal entity is ANDE Corporation. Its competitors include DDC Paternity Tests, Applied DNA Sciences and Othram; 1 of its 3 listed competitors has raised funding.

Company details

ANDE is engaged in delivering Rapid DNA technology for diverse applications including human identification, energy, and biosurveillance. Solutions are designed to be mobile and rugged, enabling integration into daily operations across different sectors. The technology is validated by over 50 scientific and public safety organizations globally. Emergency response support is also offered through the ANDE Fly Team for critical cases and mass casualty incidents.

  • Headquarters Waltham, United States
  • Employees 49
  • Founders Richard Selden
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website ande.com
  • Social LinkedIn X Facebook
  • Legal Name Ande Corporation
Key Metrics
  • Total Equity Funding
    $131.3M (USD)

    in 11 rounds

  • Latest Funding Round
    $19.75M (USD), Series C

    Apr 2020

  • Investors
    HHS

    & 1 more

  • Employee Count
    49

Products & Services of ANDE

ANDE offers a comprehensive portfolio of products and services, including Rapid DNA for Human Identification, Rapid DNA for Energy, and Rapid DNA for Biosurveillance.

Rapid DNA for Human Identification
Biotechnology

Rapid DNA technology is used for human identification.

Rapid DNA for Energy
Biotechnology

DNA technology is applied in energy sector solutions.

Rapid DNA for Biosurveillance
Biotechnology

DNA technology is utilized for biosurveillance monitoring purposes.

Funding Insights of ANDE

ANDE has successfully raised a total of $131.3M across 11 strategic funding rounds. The most recent funding activity was a Series C round of $19.75 million completed in April 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $131.3M
  • Total Rounds 11
  • Last Round Series C β€” $19.75M
  • First Round $498,563

    (Sep 2008)

  • Investors Count 2

Latest 10 of 11 funding rounds of ANDE with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2020$19.75MSeries C––
–
Jun 2019$31.01MSeries C––
–
Nov 2018$47.63MSeries C––
–
Jan 2018$16MSeries B––
–
Jun 2017$16.91MSeries B––
–
Jul 2011$594,001Grant––
Aug 2009$4.82MGrant––
Jul 2009$3.88MGrant––
Jul 2009$880,045Grant––
Sep 2008$494,319Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in ANDE

ANDE has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Ojp.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov
Federal justice system funding, training, and resources are provided.
ojp.gov
Premium access

Investor details for ANDE

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of ANDE

17 people are tracked at ANDE (11 in leadership, 6 in team); the tracked headcount is 49.

NameRoleGroup
Richard Selden
Founder & ChairmanLeadership
Melissa Schwandt
Director of Field Science & Customer SupportLeadership
Eric Fang
President, ANDE ChinaLeadership
Steve.Lowe Lowe
Chief Commercial OfficerLeadership
George Heinrichs
Chief Executive OfficerLeadership
Julie French
Senior Vice President, Global Scientific SupportLeadership
Steve Bohn
Chief Financial OfficerLeadership
Eddy Dolan
Managing Director Latin AmericaLeadership
Sandra Lea Otsuki
VP Of PeopleLeadership
Troy Deppey
Vice President Of Global OperationsLeadership
Brian B.
Vice President Global MarketsLeadership
Lewis Shaw
Field Application ScientistTeam
Kristen D.
Field Application ScientistTeam
Chad Gemmen
Field Service EngineerTeam
James Y.
Global Senior Support EngineerTeam
Todd Simon
Corporate ControllerTeam
Grace Whittemore
Staff AccountantTeam
Premium access

Complete people profiles for ANDE

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of ANDE

3 dated milestones of ANDE across 20 years, from founding to its latest funding, stage changes and deals.

  1. Founded ANDE is founded.
  2. Funding First funding round of $499K.
  3. Funding Latest funding round, Series C, of $19.8M.

Competitors of ANDE

ANDE has 3 listed competitors in our database, 1 of them funded. They include DDC Paternity Tests, Applied DNA Sciences and Othram.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
dnacenter.com1995Fairfield, United States
DNA tests and personalized diagnostics are provided for various specialties.
adnas.com1983Stony Brook, United States55
Botanical-DNA-based security and authentication solutions are developed.
othram.com2018Houston, United States$33.16M22
Genomic services are provided for forensic investigations and research.
Premium access

Detailed competitors of ANDE

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of ANDE

The website of ANDE (ande.com) receives about 5.1K visits a month.

  • Monthly visits
    5.1K

    ▼ 17.2% vs previous month

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as ANDE (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Ande

Premium access

Complete news archive for ANDE

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ANDE

ANDE was founded in 2000 and raised its 1st funding round 8 years after it was founded.

ANDE is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.

ANDE is a funded company, having raised a total of $131.3M across 11 funding rounds to date. The company's 1st funding round was a Grant of $494.32K, raised on Sep 2008.

ANDE has 49 employees.

ANDE is engaged in delivering Rapid DNA technology for diverse applications including human identification, energy, and biosurveillance. Solutions are designed to be mobile and rugged, enabling integration into daily operations across different sectors. The technology is validated by over 50 scientific and public safety organizations globally. Emergency response support is also offered through the ANDE Fly Team for critical cases and mass casualty incidents.

ANDE's top competitors include DDC Paternity Tests, Applied DNA Sciences and Othram.

ANDE offers Rapid DNA for Human Identification, Rapid DNA for Energy, and Rapid DNA for Biosurveillance.

ANDE has 2 investors. Key investors include HHS, and Ojp.

ANDE operates through Ande Corporation.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available